Matches in Nanopublications for { ?s ?p "[We found that myelodysplastic chronic myelomonocytic leukemias are characterized by mutations in transcription/epigenetic regulators (ASXL1, RUNX1, TET2) and splicing genes (SRSF2) and the absence of mutations in signaling genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP978489.RAdXDPQ7O-aO-x56WC38jfNAEM-3xO_nUhX3I_NuKen9A130_assertion description "[We found that myelodysplastic chronic myelomonocytic leukemias are characterized by mutations in transcription/epigenetic regulators (ASXL1, RUNX1, TET2) and splicing genes (SRSF2) and the absence of mutations in signaling genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978489.RAdXDPQ7O-aO-x56WC38jfNAEM-3xO_nUhX3I_NuKen9A130_provenance.
- assertion description "[We found that myelodysplastic chronic myelomonocytic leukemias are characterized by mutations in transcription/epigenetic regulators (ASXL1, RUNX1, TET2) and splicing genes (SRSF2) and the absence of mutations in signaling genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1020994.RA5Y3WJEE6PFWguYxO5czf41sWr-hU1SUyMZ9itEZ2Jp4130_assertion description "[We found that myelodysplastic chronic myelomonocytic leukemias are characterized by mutations in transcription/epigenetic regulators (ASXL1, RUNX1, TET2) and splicing genes (SRSF2) and the absence of mutations in signaling genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1020994.RA5Y3WJEE6PFWguYxO5czf41sWr-hU1SUyMZ9itEZ2Jp4130_provenance.